Glioblastoma Multiforme: Five-year Experience at a Tertiary Cancer Centre in North India

Malik Tariq Rasool; Ishtiyaq Ahmad Dar; Sarbjit Singh Chhiber; Shareefa Akhter; Saquib Zaffar Banday; Mohib-ul Haq Malik; Mohammad Maqbool Lone; Fir Afroz

doi:10.4103/2321-7006.301995

Users Online: 637

ORIGINAL ARTICLE

Year : 2020 \| Volume : 8 \| Issue : 2 \| Page : 27-30

Glioblastoma Multiforme: Five-year Experience at a Tertiary Cancer Centre in North India Malik Tariq Rasool¹, Ishtiyaq Ahmad Dar², Sarbjit Singh Chhiber³, Shareefa Akhter⁴, Saquib Zaffar Banday⁵, Mohib-ul Haq Malik⁶, Mohammad Maqbool Lone⁷, Fir Afroz⁸ ¹ Associate Professor, Department of Radiation Oncology, State Cancer Institute, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, India ² Senior Resident, Department of Radiation Oncology, State Cancer Institute, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, India ³ Additional Professor, Department of Neurosurgery, State Cancer Institute, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, India ⁴ Senior Resident, Department of Hematopathology, State Cancer Institute, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, India ⁵ Assistant Professor, Department of Medical Oncology, State Cancer Institute, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, India ⁶ Additional Professor & Head, Department of Radiological Physics, State Cancer Institute, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, India ⁷ Professor & Head, Department of Radiation Oncology, State Cancer Institute, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, India ⁸ Professor, Department of Radiation Oncology, State Cancer Institute, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, India Correspondence Address: Malik Tariq Rasool Associate Professor, Department of Radiation Oncology, State Cancer Institute, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar India Source of Support: None, Conflict of Interest: None DOI: 10.4103/2321-7006.301995

Background: Glioblastoma Multiforme (GBM) is one of the most common brain tumors. Despite multimodal treatment with surgery and chemoradiotherapy, survival outcome remains bleak. Many patients do not tolerate and complete such aggressive treatment. Our Center is the largest tertiary care referral hospital in the region; we report our findings about 5-year outcome in these patients. Methods: From January 2014 to December 2018, we conducted a retrospective observational study. We included patients with histopathologically proven diagnosis of GBM. Descriptive statistics of patient data was retrieved from patient files at Hospital Based Cancer Registry (HBCR) at our State Cancer Institute (SCI). All the data was recorded and analyzed using appropriate statistical methods. Results: 54 histopathologically proven cases of GBM were enrolled. Most patients were in the fifth and sixth decade of life, with a male to female ratio of 2:1. Headache was the most common presenting symptom in 23 (42.5%) patients followed by seizures in 13 (24%) patients. The average lesion size was 4.7 cm. Gross total excision was done in 12 (22%) patients, near total excision in 8 (15%) patients. 48 (89%) patients received radiation therapy concurrent with temozolomide. 4 (7.4%) patients had complete response with chemoradiotherapy. Median survival was 16 months. Patients who underwent Gross total excision or near total excision had a median survival of 15.9±3.56 months, whereas patients who underwent subtotal excision had a median survival of 8.29±4.14 months. Patients who completed trimodality therapy had better survival. Conclusion: Patients receiving trimodality therapy with gross total excision and adjuvant chemoradiation achieve best survival rates. Advanced age, poor performance score, larger tumor size, deep seated lesions, suboptimal tumor excision, and steroid dependency carry poor prognosis.



[PDF]*

Table of Contents

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics
Viewed	68
Printed	2
Emailed	0
PDF Downloaded	10
Comments	[Add]